ESMO launches new principles for humanising scientific reporting to strengthen the communication of cancer research By Ogkologos - October 21, 2026 6 0 Facebook Twitter Google+ Pinterest WhatsApp Source RELATED ARTICLESMORE FROM AUTHOR Clinical Activity of Talazoparib Plus Enzalutamide Demonstrated in Patients with High-Volume mHNPC, but Without Clear Benefit Over Enzalutamide in Biomarker-Unselected Population FDA Approves Daraxonrasib for Metastatic Pancreatic Adenocarcinoma Chemotherapy-Free Regimen of Targeted Agent and Immunotherapeutic Superior to Imatinib and Chemotherapy Among Adult Patients with Ph-positive ALL MOST POPULAR FDA Approves Vimseltinib for Symptomatic Tenosynovial Giant Cell Tumour April 4, 2025 FDA Approves Zidesamtinib for ROS1-positive Non-Small Cell Lung Cancer September 16, 2026 Όροι χρήσης και προϋποθέσεις January 18, 2019 EMA Recommends Extension of Indications for Ponatinib Associated with a New... August 7, 2026 Load more HOT NEWS Grandma Saves Her Money To Put Up A Billboard For Everyone... Mental Health Awareness for Health Care Providers For Women with Breast Cancer, Regular Exercise May Improve Survival HER2 Expression is a Determinant of Sensitivity to Trastuzumab Deruxtecan in...
